Variable | Data |
---|---|
Age, year ± SD | 57.7 ± 13.3 |
Gender, n (%) | |
Male | 311 (76.8%) |
Woman | 94 (23.2%) |
Diagnosis, n (%) | |
Lung cancer | 294 (72.6%) |
Bening Lung mass | 111 (27.4%) |
Disease localization, n (%) | |
Right | 237 (59.0%) |
Left | 168 (41.0%) |
BMI, kg/m2 ± SD | 25.6 ± 4.7 |
EF value, n (%) | |
< 60 | 60 (14.8%) |
≥ 60 | 345 (85.2%) |
HT presence | 149 (36.8%) |
COPD presence | 79 (19.5%) |
Neoadjuvan, n (%) | 25 (6.2%) |
Resection type, n (%) | |
Pneumonectomy | 71 (17.5%) |
Lobectomy | 293 (72.3%) |
Wedge resection | 41 (10.1%) |
Type of operation, n (%) | |
Thoracotomy | 318 (78.5%) |
VATS | 87 (21.5%) |
Operation time, hours ± SD | 3.9 ± 0.7 |
Intraoperative blood loss, ml ± SD | 369 ± 335.0 |
Intraoperative MAP, mmHg ± SD | 66.1 ± 11.8 |
Intraoperative heart rate, n/min ± SD | 67.6 ± 11.3 |
Intraoperative Apgar Score, n ± SD | 6.5 ± 1.5 |
Postoperative APACHE II, unit ± SD | 8.1 ± 3.3 |
Postoperative SOFA, unit ± SD | 0.79 ± 1.56 |
Reoperation, n (%) | 24 (5.9%) |
Postoperative complications, n (%) | 151 (37.2%) |
Mortality, n (%) | 5 (1.2%) |